|
MTPAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68036000000038E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.188500E-02 |
| Normal-vs-Stage2 |
1.217970E-02 |
| Normal-vs-Stage3 |
2.40209999669005E-08 |
| Normal-vs-Stage4 |
1.77210000007477E-07 |
| Stage1-vs-Stage2 |
1.802220E-01 |
| Stage1-vs-Stage3 |
4.21820000000572E-05 |
| Stage1-vs-Stage4 |
1.192250E-04 |
| Stage2-vs-Stage3 |
1.229780E-01 |
| Stage2-vs-Stage4 |
1.020040E-01 |
| Stage3-vs-Stage4 |
7.306000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53712999999556E-05 |
| Normal-vs-AfricanAmerican |
2.350100E-02 |
| Normal-vs-Asian |
5.104400E-01 |
| Caucasian-vs-AfricanAmerican |
6.949000E-01 |
| Caucasian-vs-Asian |
4.579600E-01 |
| AfricanAmerican-vs-Asian |
5.971400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4927000002718E-07 |
| Normal-vs-Female |
3.672000E-02 |
| Male-vs-Female |
1.161900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.738200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.823710E-03 |
| Normal-vs-Age(61-80Yrs) |
1.29019999994817E-06 |
| Normal-vs-Age(81-100Yrs) |
6.142500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.063800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.327600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.709200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.029380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.788600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.284600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.893200E-01 |
| Normal-vs-Grade 2 |
3.258300E-02 |
| Normal-vs-Grade 3 |
3.03769999998593E-06 |
| Normal-vs-Grade 4 |
6.25739460247132E-11 |
| Grade 1-vs-Grade 2 |
1.088030E-01 |
| Grade 1-vs-Grade 3 |
6.139000E-03 |
| Grade 1-vs-Grade 4 |
1.97087000000096E-05 |
| Grade 2-vs-Grade 3 |
6.318600E-03 |
| Grade 2-vs-Grade 4 |
6.23520000075928E-08 |
| Grade 3-vs-Grade 4 |
1.400310E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.373200E-01 |
| Normal-vs-ccB subtype |
5.80760000090663E-08 |
| ccA subtype-vs-ccB subtype |
1.86269999979949E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.83560000000572E-05 |
| Normal-vs-N1 |
5.387800E-02 |
| N0-vs-N1 |
5.705600E-01 |
|
|
